Novartis takes aim at Roche's star MS drug
Swiss drugmaker Novartis on Friday stepped up its challenge to Roche's multiple sclerosis franchise, highlighting study results for its MS hopeful ofatumumab that could compete with its cross-town rival's drug Ocrevus.
from Reuters: Health News https://ift.tt/2ML3o2v
from Reuters: Health News https://ift.tt/2ML3o2v
Comentarii
Trimiteți un comentariu